Recent Studies Of Vytorin, Avandia Prompt Debate About FDA Approval Process For New Medications
Recent studies that raised questions about the benefits of the cholesterol medication Vytorin, manufactured by Merck and Schering-Plough, and the
More: continued here
Filed under: Cholesterol on January 29th, 2008